Mode
Text Size
Log in / Sign up

Interferon-alpha gel reduces recurrence in nasal inverted papilloma patients compared to surgery alone

Interferon-alpha gel reduces recurrence in nasal inverted papilloma patients compared to surgery alo…
Photo by Navy Medicine / Unsplash
Key Takeaway
Note that interferon-alpha gel did not significantly reduce recurrence in 42 patients with nasal inverted papilloma.

This randomized controlled trial included 42 newly diagnosed nasal inverted papilloma patients. The intervention involved local application of interferon-alpha gel during and after surgery. The comparator group received endoscopic tumor resection without interferon-alpha gel. Follow-up lasted 12.0 months.

The primary outcome measured DIP endoscopic scoring system results at 3, 6, and 12 months. Positive expression rates of HPV6/11 in NIP tissues were 52.38% (22/42) in the study population. This rate was higher than the nasal polyp control group at 8.33% (1/12) with a p-value <0.05.

DIP scores between the interferon treatment group and control group showed no statistically significant differences (p > 0.05). Safety data were not reported for adverse events, serious adverse events, discontinuations, or tolerability. The study limitations were not reported. Funding or conflicts of interest were not reported.

Practice relevance was not reported. The evidence is limited by the small sample size of 42 patients and the lack of reported safety data. Clinicians should interpret these findings cautiously given the absence of significant differences in recurrence scores.

Study Details

Study typeRct
EvidenceLevel 2
Follow-up12.0 mo
PublishedMay 2026
View Original Abstract ↓
To investigate the expression of HPV 6/11 in NIP tissues and evaluate the adjuvant therapeutic effect of interferon-α gel on HPV-positive NIP patients. Forty-two newly diagnosed Nasal Inverted Papilloma(NIP) patients were included, and the expression of HPV6/11 in tissues was detected using fluorescence in situ hybridization with specific probes. Twenty-two HPV-positive patients were randomly divided into an interferon treatment group(=11) and a control group(=11). Both groups underwent endoscopic tumor resection, with the treatment group receiving local application of interferon-α gel during and after surgery. Postoperative recovery was assessed using the DIP endoscopic scoring system at 3, 6, and 12 months. The positive expression rate of HPV6/11 in NIP tissues was 52.38%(22/42), which was significantly higher than that in the nasal polyp control group(8.33%, 1/12)(<0.05). Among HPV-positive NIP patients, there were no statistically significant differences were observed in DIP scores between the interferon treatment group and the control group at 3, 6, and 12 months postoperatively(>0.05). HPV6/11 shows high expression in NIP tissues, but the use of interferon-α gel did not improve postoperative recovery in HPV-positive patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.